Skip to main content

Polymeric Hydroxamic Acids for Iron Chelators Therapy

  • Chapter
Polymeric Materials in Medication

Part of the book series: Polymer Science and Technology ((POLS,volume 32))

  • 95 Accesses

Abstract

Iron chelation therapy is used to remove iron in cases of iron poisoning and Cooley’s Anemia. Cooley’s Anemia is characterized by an inability to synthesize the 3-chain of hemoglobin. Frequent transfusion, the primary treatment, introduces iron, which if not removed, accumulates to toxic levels. Deferioxamine-B(DFB), a naturally occurring tris-hydroxamic acid, is presently used to treat this condition. The structural positions of the three hydroxamic acids of DFB provides a powerful chelate effect and enhances iron binding. Modeled after DFB, vinyl polymers were constructed for potential use in iron chelation. The polymer and spacers position the hydroxamic acids in a way that provides good chelation effects. Bioassay in a mouse screen (Mason Research Institute) shows that many of the polymers are active in removing iron in vivo. We will discuss the effect of subtle changes in the structure of the polymer on the bioactivity and the tox-icity. Such changes include the nature of the spacer group and the presence or absence of a methyl group on a polymer chain or nitrogen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. H. S. Waxman and E. B. Brown, in: “Progress in Hematology”, Vol. VI, E. B. Brown and C. V. Moore, eds., Grune and Stratton, 1969, p 338.

    Google Scholar 

  2. A. I. Chernoff, Blood, The Journal of Hematology, 14, 899 (1959).

    Google Scholar 

  3. T. F. Necheles, D. M. Allen, and H. E. Finkel, “Clinical Disorders of Hemoglobin Structure and Synthesis”, Meredith Corp., New York, 1969.

    Google Scholar 

  4. D. J. Weatherall, in: “Development of Iron Chelators for Clinical Use”, A. E. Martell, W. F. Anderson, and D. G. Badman, eds., Elsevier North Holland, Inc., New York 1981, p. 3.

    Google Scholar 

  5. Assessment of Cooley’s Anemia Reaserch and Treatment, DHEW Publication No. (NIH) 79-1653, March 1979.

    Google Scholar 

  6. B. Modell in: “Progress in Hematology”, Vol. XI, E. B. Brown, ed., Grune and Stratton, New York, 1979, p 267.

    Google Scholar 

  7. W. F. Anderson in: “Inorganic Chemistry in Biology and Medicine”, A. E. Martell, ed., ACS Symposium Series 140, American Chemical Society, Washington, DC, 1980, p 251.

    Chapter  Google Scholar 

  8. E. C. Zaino and R. H. Roberts, eds., “Chelation Therapy in Chronic Iron Overload”, Symposia Specialists, Inc., Miami, Florida, 1977.

    Google Scholar 

  9. W. F. Anderson and M. C. Hiller, eds., “Development of Iron Chelators for Clinical Use”, U. S. Dept. of Health Education and Welfare, DHEW Publication No. (NIH) 77-994, Bethesda, MD, 1975.

    Google Scholar 

  10. D. J. Weatherall and J. B. Clegg, “The Thalassaemia Syndromes”, 3rd ed., Blackwell Scientific Publications, Oxford, 1981.

    Google Scholar 

  11. R. D. Proper and D. G. Nathan in: “Chelation Therapy in Chronic Iron Overload”, E. C. Zaino and R. H. Roberts, eds., Symposia Specialists, Miami, Florida, 1977, p 17.

    Google Scholar 

  12. A. Winston and D. Kirchner, Macromolecules, 11, 597, (1978).

    Article  ADS  Google Scholar 

  13. D. V. P. R. Varaprasad, J. Rosthauser, and A. Winston, J. Polym. Sci., Chem. Ed., 22, 2131, (1984).

    Article  Google Scholar 

  14. A. Winston, D. V. P. R. Varaprasad, J. J. Metterville, and H. Rosenkrantz, J. Pharmacol. Exp. Ther., 232, 644 (1985).

    Google Scholar 

  15. C. G. Pitt, G. Gupta, W. E. Estes, H. Rosenkrantz, J. J. Metterville, A. L. Crumbliss, R. A. Palmer, K. W. Nordquest, K. A. Sprinkle Hardy, D. R. Whitcomb, B. R. Byers, J. E. L. Arceneaux, C. G. Gaines, C. V. Sciortino, J. Pharmacol. Exp. Ther., 208, 12 (1979).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer Science+Business Media New York

About this chapter

Cite this chapter

Winston, A., Varaprasad, D.V.P.R., Metterville, J.J., Rosenkrantz, H. (1985). Polymeric Hydroxamic Acids for Iron Chelators Therapy. In: Gebelein, C.G., Carraher, C.E. (eds) Polymeric Materials in Medication. Polymer Science and Technology, vol 32. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2245-8_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-2245-8_17

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-2247-2

  • Online ISBN: 978-1-4899-2245-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics